Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Arch Capital Group Ltd is an insurance-diversified business based in the US. Arch Capital Group shares (ACGL) are listed on the NASDAQ and all prices are listed in US Dollars. Arch Capital Group employs 4,500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$43.21|
|52-week range||$28.55 - $43.40|
|50-day moving average||$40.06|
|200-day moving average||$39.78|
|Wall St. target price||$48.27|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$4.97|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||1.74%|
|1 month (2021-09-24)||10.29%|
|3 months (2021-07-23)||12.15%|
|6 months (2021-04-23)||8.05%|
|1 year (2020-10-23)||35.84%|
|2 years (2019-10-23)||4.40%|
|3 years (2018-10-23)||60.27%|
|5 years (2016-10-21)||77.62|
Valuing Arch Capital Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Arch Capital Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Arch Capital Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Arch Capital Group shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Arch Capital Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.24. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Arch Capital Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Arch Capital Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.7 billion.
The EBITDA is a measure of a Arch Capital Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$9.5 billion|
|Operating margin TTM||27.41%|
|Gross profit TTM||$2.8 billion|
|Return on assets TTM||3.73%|
|Return on equity TTM||16.49%|
|Market capitalisation||$17.1 billion|
TTM: trailing 12 months
There are currently 5.4 million Arch Capital Group shares held short by investors – that's known as Arch Capital Group's "short interest". This figure is 2.6% up from 5.3 million last month.
There are a few different ways that this level of interest in shorting Arch Capital Group shares can be evaluated.
Arch Capital Group's "short interest ratio" (SIR) is the quantity of Arch Capital Group shares currently shorted divided by the average quantity of Arch Capital Group shares traded daily (recently around 2.3 million). Arch Capital Group's SIR currently stands at 2.39. In other words for every 100,000 Arch Capital Group shares traded daily on the market, roughly 2390 shares are currently held short.
However Arch Capital Group's short interest can also be evaluated against the total number of Arch Capital Group shares, or, against the total number of tradable Arch Capital Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Arch Capital Group's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Arch Capital Group shares in existence, roughly 10 shares are currently held short) or 0.0142% of the tradable shares (for every 100,000 tradable Arch Capital Group shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Arch Capital Group.
Find out more about how you can short Arch Capital Group stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Arch Capital Group.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 30.93
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Arch Capital Group's overall score of 30.93 (as at 12/31/2018) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Arch Capital Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 5.65/100
Arch Capital Group's environmental score of 5.65 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Arch Capital Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.53/100
Arch Capital Group's social score of 15.53 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Arch Capital Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 16.75/100
Arch Capital Group's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Arch Capital Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Arch Capital Group scored a 1 out of 5 for controversy – the highest score possible, reflecting that Arch Capital Group has managed to keep its nose clean.
|Total ESG score||30.93|
|Total ESG percentile||47.32|
|Environmental score percentile||6|
|Social score percentile||6|
|Governance score percentile||6|
|Level of controversy||1|
We're not expecting Arch Capital Group to pay a dividend over the next 12 months.
Arch Capital Group's shares were split on a 3:1 basis on 20 June 2018. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Arch Capital Group shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Arch Capital Group shares which in turn could have impacted Arch Capital Group's share price.
Over the last 12 months, Arch Capital Group's shares have ranged in value from as little as $28.55 up to $43.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Arch Capital Group's is 0.8868. This would suggest that Arch Capital Group's shares are less volatile than average (for this exchange).
Arch Capital Group Ltd. , together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service contract reimbursement products; directors' and officers' liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; medical professional and general liability insurance coverages; and workers' compensation and umbrella liability, as well as commercial automobile, and inland marine products. It also provides property, energy, marine, and aviation insurance; travel insurance; accident, disability, and medical plan insurance coverages; captive insurance programs; employer's liability; and contract and commercial surety coverages. This segment markets its products through a group of licensed independent retail and wholesale brokers. Its Reinsurance segment provides reinsurance for third party liability and workers' compensation exposures; marine and aviation reinsurance; surety, accident and health, workers' compensation catastrophe, agriculture, trade credit, and political risk products; reinsurance protection for catastrophic losses, and personal lines and commercial property exposures; life reinsurance; casualty clash; and risk management solutions. This segment markets its reinsurance products through brokers.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.